These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 508185)

  • 21. Prolonged release medication in the treatment of eye disease.
    Lerman S
    Isr J Med Sci; 1972; 8(8):1402-5. PubMed ID: 4647794
    [No Abstract]   [Full Text] [Related]  

  • 22. Topical antibiotic therapy of staphylococcal keratitis.
    Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1977 Sep; 95(9):1634-7. PubMed ID: 901273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An ocular bioavailability comparison in rabbits of prednisolone acetate after repeated topical applications formulated as a high-viscosity gel and as an aqueous suspension.
    Johansen S; Rask-Pedersen E; Prause JU
    Acta Ophthalmol Scand; 1996 Jun; 74(3):259-64. PubMed ID: 8828723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penetration of topically administered prednisolone acetate into the human aqueous humor.
    Leibowitz HM; Berrospi AR; Kupferman A; Restropo GV; Galvis V; Alvarez JA
    Am J Ophthalmol; 1977 Mar; 83(3):402-6. PubMed ID: 848546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topically administered corticosteroids and treatment of inflammatory keratitis.
    Leibowitz HM; Kupferman A
    Invest Ophthalmol; 1975 May; 14(5):337-40. PubMed ID: 1126821
    [No Abstract]   [Full Text] [Related]  

  • 26. Topical fluorometholone reduces stromal inflammation after photorefractive keratectomy.
    Campos M; Abed HM; McDonnell PJ
    Ophthalmic Surg; 1993 Oct; 24(10):654-7. PubMed ID: 8259241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis.
    Schreiber W; Olbrisch A; Vorwerk CK; König W; Behrens-Baumann W
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2634-43. PubMed ID: 12766067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary Neisseria meningitidis Keratitis.
    Elias JA; Pandit RT
    Cornea; 2009 Jul; 28(6):714-5. PubMed ID: 19512893
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of the prophylactic effects of 2-deoxycytidine and prednisolone for high-dose intravenous cytarabine-induced keratitis.
    Lazarus HM; Hartnett ME; Reed MD; Murphy BF; Lass JH
    Am J Ophthalmol; 1987 Nov; 104(5):476-80. PubMed ID: 3314526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of dexamethasone acetate as a topical ophthalmic formulation.
    Leibowitz HM; Kupferman A; Stewart RH; Kimbrough RL
    Am J Ophthalmol; 1978 Sep; 86(3):418-23. PubMed ID: 717508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Study of Ocular Pharmacokinetics of Gatifloxacin Between Continuous Lavage and Hourly Topical Instillation in Rabbits.
    Zhao X; Shen X; Zhang X; Chen S; Lu H; Wang M
    Cornea; 2018 Nov; 37(11):1457-1462. PubMed ID: 30124589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topically applied steroids in corneal disease. VI. Kinetics of prednisolone sodium phosphate.
    Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1974 Oct; 92(4):331-4. PubMed ID: 4416663
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of collagen shields containing amphotericin B in the treatment of experimental Candida albicans-induced keratomycosis in rabbits.
    Pleyer U; Legmann A; Mondino BJ; Lee DA
    Am J Ophthalmol; 1992 Mar; 113(3):303-8. PubMed ID: 1543224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
    Oguz H; Ozbilge H; Oguz E; Gurkan T
    Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent keratitis due to 'lost' contact lenses.
    Tarafdar S; Ramamurthi S; Ramaesh K
    Cont Lens Anterior Eye; 2013 Apr; 36(2):101-2. PubMed ID: 23131319
    [No Abstract]   [Full Text] [Related]  

  • 36. Topical anti-inflammatory agents in an animal model of microbial keratitis.
    Gritz DC; Lee TY; Kwitko S; McDonnell PJ
    Arch Ophthalmol; 1990 Jul; 108(7):1001-5. PubMed ID: 2369336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical cyclosporine-A versus prednisolone for herpetic stromal keratitis: a randomized controlled trial.
    Peyman A; Nayebzadeh M; Peyman M; Afshari NA; Pourazizi M
    Acta Ophthalmol; 2019 Mar; 97(2):e194-e198. PubMed ID: 30284385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical ciprofloxacin treatment of Pseudomonas keratitis in rabbits.
    O'Brien TP; Sawusch MR; Dick JD; Gottsch JD
    Arch Ophthalmol; 1988 Oct; 106(10):1444-6. PubMed ID: 3140772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prednisolone phosphate penetration into and through the cornea.
    Green K; Downs SJ
    Invest Ophthalmol; 1974 Apr; 13(4):316-9. PubMed ID: 4818819
    [No Abstract]   [Full Text] [Related]  

  • 40. Topically applied 1% voriconazole induces dysplastic changes on the ocular surface: animal study.
    Arikan G; Karatas E; Lebe B; Ayhan Z; Utine CA; Kutsoylu OE; Gunenc U; Yilmaz O
    Cutan Ocul Toxicol; 2018 Dec; 37(4):328-331. PubMed ID: 29633868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.